[Pneumococcal vaccine: overview about the protective efficacy in different high risk groups and new progress in the development of a conjugate pneumococcal vaccine]

Abstract

The author presents a review about the protective efficacy of polyvalent pneumococcal polysaccharide vaccines in different groups at high risk for severe pneumococcal infection and the difficulties in the development of a conjugate pneumococcal vaccine capable of offering protection to younger children.